7 projets européens trouvés
Recherche sur 125080 projets européens
TERMINÉ
Heart OMics in AGEing (HOMAGE)
Date du début: 1 févr. 2013, Date de fin: 31 janv. 2019,
As more people survive into old age, the prevalence of heart failure (HF), one of the most common and debilitating diseases in older people, will rise still further. Delaying or preventing HF will have great benefit to those at personal risk, their families, society and the economy. HOMAGE aims to provide a biomarker (BM) approach that will a) help identify i. patients at high risk of developing ...
Voir le projet
22
Participants partenaires
TERMINÉ
Development of a sustainable exploitation scheme for Europe’s Rare Earth ore deposits (EURARE)
Date du début: 1 janv. 2013, Date de fin: 31 déc. 2017,
With numerous European industries heavily depended on imported REE raw materials, there is a need for EU to secure a viable supply of REE minerals as well as develop from the ground up the currently non-existent European REE extraction and processing industry. The goal of the EURARE project will be (i) to characterize the potential REE resources in Europe; and (ii) to research, develop, optimize a ...
Voir le projet
23
Participants partenaires
TERMINÉ
European clinical study for the application of regenerative heart valves (ESPOIR)
Date du début: 1 janv. 2012, Date de fin: 31 déc. 2016,
Acquired and congenital heart disease can necessitate heart valve replacement. However, current heart valve substitutes are not considered ideal as they need anticoagulation, bearing the risk of bleeding when manufactured from non-organic material, or they degenerate when they derive from animals or human tissue donators (homografts) thereby leading to frequent reoperation especially in the young ...
Voir le projet
15
Participants partenaires
TERMINÉ
Towards Tissue Engineering Solutions for Cardiovascular Surgery (TECAS)
Date du début: 1 janv. 2013, Date de fin: 31 déc. 2016,
"The aim of the TECAS ITN is to integrate the major European contributors in the field of cardiovascular tissue engineering (TE) and regenerative medicine (RM), to generate a coherent framework of expertise which will facilitate the training and career development of early stage researchers (ESRs) in the field. In particular, the intention of this ITN is to focus on the clinical needs of cardiac v ...
Voir le projet
7
Participants partenaires
TERMINÉ
Virtual certification of acoustic performance for freight and passenger trains (ACOUTRAIN)
Date du début: 1 oct. 2011, Date de fin: 31 déc. 2014,
ACOUTRAIN will simplify and improve the acoustic certification process of new rolling stock, in particular relating to the TSI Noise. Today the need of conformity assessment for a new vehicle according to the TSI Noise represents a significant element of both cost and time to market due to the need to carry out expensive and time consuming tests. The goal of the proposed project is to speed up the ...
Voir le projet
15
Participants partenaires
TERMINÉ
Genetic testing in Europe - Network for the further development, harmonization, validation and standardization of services (EUROGENTEST2)
Date du début: 1 janv. 2011, Date de fin: 31 déc. 2013,
EuroGentest is an FP6 European network for the harmonization of genetic testing and for the further improvement of quality in genetic services across Europe.This proposal is to support EuroGentest2, a Coordination Action that will cover the different aspects of quality assurance of genetic practice and has all the ingredients to fulfil the needs. EuroGentest2 will be concerned with setting the tar ...
Voir le projet
22
Participants partenaires
TERMINÉ
Neurobiological Mechanisms of Memory Loss in Alzheimer's Disease (MEMOLOAD)
Date du début: 1 févr. 2008, Date de fin: 31 juil. 2013,
"The MEMOLOAD project will focus on the molecular and biological mechanisms underlying memory loss that occurs in Alzheimer’s disease, the leading cause of dementia and an enormous medical, social and economic challenge to Europe. Several lines of evidence point to accumulation of beta-amyloid peptide (Aß) in the brain as the key pathologic event in the disease. There is growing evidence that ...
Voir le projet